“Long-Term Safety and Disease Control of Ruxolitinib Cream Among Adolescents With Atopic Dermatitis: Results From Two Phase 3 Studies”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): s28. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/1545.